FENC Stock Analysis: Buy, Sell, or Hold?
FENC - Fennec Pharmaceuticals Inc. Common Stock
$9.97
0.22 (2.26%)
▲
5d:
+7.9%
30d:
+49.25%
90d:
+14.07%
WAIT
LOW Confidence
Analysis Updated: May 21, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When FENC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: FENC is 16.7% above its trading range ($8.54). Market expects -2.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: FENC is 16.7% above its trading range ($8.54). Market expects -2.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.03
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.06
23.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FENC is currently trading at $9.97, which is considered extended relative to its 30-day fair value range of $6.04 to $8.54. The stock's valuation (Forward PE: 9.6) is in line with its historical norms (10.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FENC is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $10.27.
Market Sentiment: FENC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.17 (+52.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FENC is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $10.27.
Market Sentiment: FENC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.17 (+52.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.04 -
$8.54
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BEARISH: Price significantly overextended (+16.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 52.1% below Wall St target ($15.17)
- WARNING: Recommendation downgraded due to 16.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$6.04 -
$8.54
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.75
Resistance Level
$10.27
Current Trend
Sideways
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.60
Wall Street Target
$15.17
(+52.1%)
Revenue Growth (YoY)
72.6%
Profit Margin
-16.4%
Valuation Discount vs History
-2.5% cheaper
PE vs Historical
9.6 vs 10.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.5%
(market-implied from PE analysis)
1-Year Target
$9.72
(-3%)
2-Year Target
$9.48
(-5%)
3-Year Target
$9.24
(-7%)
3-Yr Target (if PE normalizes)
(PE: 10→10)
$10.01
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 233.1%)
$77.06
(+673%)
Base:
(SPY PE: 9.6, Growth: 233.1%)
$33.65
(+238%)
Bear:
(PE: 8.2, Growth: 233.1%)
$28.60
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.6 to 10.4
Stabilization Target:
$10.80
(+8.3%)
PE Expansion Potential:
+8.3%
Share & Embed Analysis
Last updated: May 21, 2026 10:08 PM ET
Data refreshes hourly during market hours. Next update: 11:07 PM
Data refreshes hourly during market hours. Next update: 11:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FENC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Rosty Raykov
SELL
10946 shares
2026-04-01
Rosty Raykov
SELL
10349 shares
2026-02-02
Southpoint Capital Advis…
SELL
1000000 shares
2025-12-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 55 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$293 | 62 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 47 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 68 BUY |
